Impact of aortic stiffness on survival in end-stage renal disease

Circulation

Volumn 99, Issue 18, 1999, Pages 2434-2439

  Blacher, Jacques ^a   Guerin, Alain P ^b   Pannier, Bruno ^b   Marchais, Sylvain J ^b   Safar, Michel E ^a   London, Gérard M ^b,c  

^a HÔPITAL BROUSSAIS   (France)

^b Department of Nephrology   (France)

^c CH Manhes   (France)

Author keywords

Aorta; Kidney; Survival

Indexed keywords

ADULT; AGED; AORTA DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOGRAPHY; ECHOCARDIOGRAPHY; ELASTICITY; FEMALE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE PRESSURE; RIGIDITY; SURVIVAL;

EID: 0033545950     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.18.2434     Document Type: Article

References (35)

1. Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med. 1974;290: 697-701.
2. Rostand SG, Gretes JC, Kirk KA, Rutsky EA, Andreoli TE. Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis. Kidney Int. 1979;16:600-611.
3. London GM, Guérin AP, Marchais SJ, Pannier B, Safar ME, Day M, Metivier F. Cardiac and arterial interactions in end-stage renal disease. Kidney Int. 1996;50:600-608.
4. Nichols WW, O'Rourke MF. Vascular impedance. In: McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles. 4th ed. London, UK: Edward Arnold; 1998:54-97, 243-283, 347-395.
5. Darné B, Girerd X, Safar M, Cambien F, Guize L. Pulsatile versus steady component of blood pressure. a cross-sectional and prospective analysis on cardiovascular mortality. Hypertension. 1989;13:392-400.
6. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham study. N Engl J Med. 1990;232:1561-1566.
7. Silberberg JS, Barre PE, Prichard SS, Sniderman AD. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int. 1989;36:286-290.
8. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray D, Barre PE. Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int. 1996;49:1428-1434.
9. Iseki K, Miyasato F, Tokuyama K, Nishime K, Uehara H, Shiohira Y, Sunagawa H, Yoshihara K, Yoshi S, Toma S, Kowatari T, Wake T, Oura T, Fukiyama K. Low diastolic blood pressure, hypoalbuminemia, and risk of death in cohort of chronic hemodialysis patients. Kidney Int. 1997;51: 1212-1217.
10. Avolio AP, Chen S, Wang R, Zhang C, Li M, O'Rourke MF. Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. Circulation. 1983;68:50-58.
11. Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac A-M, Target R, Levy BI. Assessment of arterial distensibility by automatic pulse wave velocity measurement: validation and clinical application study. Hypertension. 1995;26:485-490.
12. Sahn DJ, De Maria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiographic measurements. Circulation. 1978;58:1072-1083.
13. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation. 1977;55:613-618.
14. London GM, Marchais SJ, Guerin AP, Metivier F, Safar ME, Fabiani F, Froment L. Salt and water retention and calcium blockade in uremia. Circulation. 1990;82:105-113.
15. British Standards Institution. Precision of Test Methods, 1: Guide for the Determination of Reproducibility for a Standard Test Method. London, England: British Standards Institution; 1979. BS 5497, part 1.
16. Safar ME, Frohlich ED. The arterial system in hypertension: a prospective view. Hypertension. 1995;26:10-14.
17. Lehmann ED, Gosling RG, Sönksen PH. Arterial wall compliance in diabetes. Diabet Med. 1992;9:114-119.
18. Wada T, Kodaira K, Fujishiro K, Maie K, Tsukiyama E, Fukumoto T, Uchida T, Yamazaki S. Correlation of ultrasound-measured common carotid artery stiffness with pathological findings. Arterioscler Thromb. 1994;14:479-482.
19. Hirai T, Sasayama S, Kawasaki T, Yagi S. Stiffness of systemic arteries in patients with myocardial infarction. Circulation. 1989;80:78-86.
20. Blacher J, Pannier B, Guerin A, Marchais S, Safar M, London G. Impact of carotid stiffness on cardiovascular and all-cause mortality in end-stage renal failure. Hypertension. 1998;32:570-574.
21. Avolio A. Genetic and environmental factors in the function and structure of the arterial wall. Hypertension. 1995;26:34-37.
22. Boutouyrie P, Laurent S, Girerd X, Benetos A, Lacolley P, Abergel E, Safar M. Common carotid artery stiffness and patterns of left ventricular hypertrophy in hypertensive patients. Hypertension. 1995;25:651-659.
23. Witteman JC, Grobbee DE, Valkenburg HA, van Hemert AM, Stijnen T, Burger H, Hofman A. J-shaped relation between change in diastolic pressure and progression of aortic atherosclerosis. Lancet. 1994;343: 504-507.
24. Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel T, Laurent G. Survival as an index of adequacy of dialysis. Kidney Int. 1992;41: 1286-1291.
25. Duranti E, Imperiali P, Sasdelli M. Is hypertension a mortality risk factor in dialysis? Kidney Int 1996;55(suppl):S173-S174.
26. Salem MM, Bower J. Hypertension in the hemodialysis population: any relation to one-year survival? Am J Kidney Dis. 1996;28:737-740.
27. Mallick MP, Brunner EP, Jones E, Selwood NH. Analysis of causes of death and of the direction of management to improve survival: data from European renal association registry (ERA-EDTA). In: Death on Hemodialysis: Preventable or Inevitable? Friedman EA, ed. Dordrecht, Netherlands: Kluwer Academic Publisher; 1994:25-33.
28. Gagnon DR, Zhang TJ, Brand FN, Kannel WB. Hematocrit and the risk of cardiovascular disease: the Framingham study: a 34-year follow-up. Am Heart J. 1994;127:674-682.
29. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis. 1996;28:53-61.
30. Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA. The effect of normal as compared with low hematocrit values in patients with cardiac disease who were receiving hemodialysis and epoetin. N Engl J Med. 1998;339:584-590.
31. Iseki K, Nishime K, Uehara H, Tokuyama K, Toma S, Yoshihara K, Kowatari T, Terukina S, Osawa A, Fukiyama K. Increased risk of cardiovascular disease with erythropoietin in chronic dialysis patients. Nephron. 1996;72:30-36.
32. Berthoux F. Epidemiological data of treated end stage renal failure in the European Community (EC) during the year 1995: report of the ERA-EDTA registry and the National Registries. Figures from Annual Report of Management of Renal Failure in Europe XXVIII, 1997; 1-56.
33. Zmirou D, Benhamou P-Y, Cordonnier D, Borgel F, Balducci F, Papoz L, Hamimi S. Diabetes mellitus prevalence among dialysed patients in France (UREMIDIAB Study). Nephrol Dial Transplant. 1992;7: 1092-1097.
34. Fassbinder W, Brunner FP, Brynger H, Ehrich JHH, Geerlings W, Raine AEG, Rizzoni G, Selwood NH, Tufveson G, Wing AJ. Combined report on regular dialysis and transplantation in Europe, XX, 1989. Nephrol Dial Transplant. 1991;6(suppl 1):5-47.
35. Jungers P, Skhiri H, Giatras I, Touam M, Nguyen AT, Massy Z, Zingraff J, Man NK. Incidence and causes of death in hemodialysis patients: a prospective study in the Ile de France Area. J Am Soc Nephrol. 1998; 8:196. Abstract.